PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	71-92	cyclin dependent kinase inhibitor 1A	Homo sapiens	173-176	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	71-92	cyclin dependent kinase inhibitor 1A	Homo sapiens	177-181	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	71-92	cyclin dependent kinase inhibitor 1A	Homo sapiens	238-241	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	71-92	cyclin dependent kinase inhibitor 1A	Homo sapiens	242-246	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	94-99	cyclin dependent kinase inhibitor 1A	Homo sapiens	173-176	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	94-99	cyclin dependent kinase inhibitor 1A	Homo sapiens	177-181	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	94-99	cyclin dependent kinase inhibitor 1A	Homo sapiens	238-241	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	94-99	cyclin dependent kinase inhibitor 1A	Homo sapiens	242-246	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	264-269	cyclin dependent kinase inhibitor 1A	Homo sapiens	173-176	
15716589-1	2005	Recent studies have shown that an endogenous lipoperoxidation product, 9-hydroxystearic acid (9-HSA), acts in colon carcinoma cells (HT29) as a growth inhibitor by inducing p21(WAF1) in an immediate-early, p53-independent manner and that p21(WAF1) is required for 9-HSA-mediated growth arrest in HT29 cells.	9-hydroxystearic acid	264-269	cyclin dependent kinase inhibitor 1A	Homo sapiens	177-181	
14715257-0	2004	9-Hydroxystearic acid upregulates p21(WAF1) in HT29 cancer cells.	9-hydroxystearic acid	0-21	cyclin dependent kinase inhibitor 1A	Homo sapiens	34-37	
14715257-0	2004	9-Hydroxystearic acid upregulates p21(WAF1) in HT29 cancer cells.	9-hydroxystearic acid	0-21	cyclin dependent kinase inhibitor 1A	Homo sapiens	38-42	
14715257-4	2004	In response to 9-HSA treatment of HT29 we observed cell growth arrest and increase in p21(WAF1) expression both at the transcriptional and the translational levels.	9-hydroxystearic acid	15-20	cyclin dependent kinase inhibitor 1A	Homo sapiens	86-89	
14715257-4	2004	In response to 9-HSA treatment of HT29 we observed cell growth arrest and increase in p21(WAF1) expression both at the transcriptional and the translational levels.	9-hydroxystearic acid	15-20	cyclin dependent kinase inhibitor 1A	Homo sapiens	90-94